Clinical Trials in New York

Showing 14481-14500 of 22,668 trials

Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder

NCT03056053

The main study objective is to assess the content validity and the psychometric characteristics of the Insomnia Daytime Symptoms and Impacts Questionnaire™ (IDSIQ™).

Insomnia Disorder

Idorsia Pharmaceuticals Ltd.113 participantsStarted Feb 2017

Santa Monica, California, United States • Atlanta, Georgia, United States • Las Vegas, Nevada, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

NCT02357420

The purpose of this study is to evaluate the effects of multiple dose regimens of relamorelin on vomiting episodes, gastric emptying and gastroparesis symptoms in participants with Type 1 and Type 2 diabetes mellitus and gastroparesis. Study drug (relamorelin and placebo) will be administered subcutaneously in a blinded fashion.

Diabetes MellitusDiabetes Mellitus ComplicationsGastroparesis

Allergan393 participantsStarted Jan 2015

Dothan, Alabama, United States • Huntsville, Alabama, United States • Tucson, Arizona, United States +95 more locations

Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

Find Trials by Condition in New York

Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer

Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System

Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer

Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma

Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)

Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer

A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma

Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

Study of Mepolizumab Safety Syringe in Asthmatics

An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection